Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesT2 assessment and clinical outcome following autologous matrix-assisted chondrocyte and osteochondral autograft transplantation
Osteoarthritis and Cartilage , 09/25/09
Salzmann GM et al. – These findings indicate that MACT and OCT result in a different ultrastructural outcome, which is only partially represented by the clinical picture.
Methods- Eighteen patients that underwent MACT or OCT for treatment of cartilage defects at the knee joint (nine MACT, nine OCT)
- Matched for gender (one female, eight male pairs)
- Matched for age (33.8)
- Matched for BMI (28.3)
- Matched for defect localization, and postoperative interval (41.6 months)
- T2 assessment was by T2 maps, while the clinical evaluation included the Lysholm and Cincinnati knee scores, a visual analogue scale (VAS) for pain, the Tegner activity scale, and the Short Form-36
- Global T2 values of healthy femoral cartilage (HC) were similar among groups
- T2 values of the RT following MACT (46.8 ms, SD 8.6) were significantly lower when compared to RT T2 values after OCT (55.5 ms, SD 6.7)
- MACT values were also significantly lower in comparison to HC (52.5 ms, SD 7.9) within MACT patients , while OCT values were significantly higher compared to HC (49.9 ms, SD 5.1) within OCT patients
- Clinical outcome following MACT consistently superior to that after OCT
- Only Lysholm score reached the level of significance
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/09/09
Bisphosphonate therapy: When not to monitor BMD
The Journal of Family Practice, 11/02/09
A New Drug in a New Class for Postmenopausal Osteoporosis
The Female Patient, 11/11/09
Today in Diagnostics/Radiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Bisphosphonate therapy: When not to monitor BMD
The Journal of Family Practice, 11/02/09
Medical decision making in patients with knee pain, meniscal tear, and osteoarthritis
Arthritis Care and Research , 11/04/09
Evaluation of occipitocervical subluxation in rheumatoid arthritis patients, using coronal-view reconstructive computed tomography
Spine, 11/17/09
Sponsor
Article Search
Sponsor